Cofepris Authorizes the First CAR-T Cell Clinical Trial in Mexico Against Leukemia
4 Articles
4 Articles
Mexico will conduct its first clinical trial with CAR-T cells produced in the country for adult patients with recurrent or refractory acute lymphoblastic leukemia.
The Federal Commission for the Protection against Health Risks (Cofepris) authorized the first clinical trial in Mexico with completely national-made CAR-T cells, to be carried out by the Autonomous University of Nuevo León (UANL) through the University Hospital “Dr. José Eleuterio González”. The study, identified with protocol number 7192, is aimed at adults [...] The Cofepris charge authorizes the first clinical trial with CAR-T cells made in …
• The study is aimed at adults with recurrent or refractory acute lymphoblastic leukemia and... The COFEPRIS charge authorizes the first clinical trial with CAR-T cells manufactured in Mexico by the Universidad Autónoma de Nuevo León appeared first in Cadena Politica.
The protocol is the result of the scientific, technical and ethical evaluation carried out by the Universidad Autónoma de Nuevo León through the “Dr. José Eleuterio González” University Hospital. The post Authorizes Cofepris first clinical trial with CAR-T cells for adults with recurrent or refractory acute lymphoblastic leukemia appeared first on Capital Mexico.
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
